Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature

Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature

Extramedullary multiple myeloma (EMM) is an aggressive sub-entity of multiple myeloma (MM). Despite an excellent improvement in survival for most patients with MM over recent decades, the overall survival (OS) of patients with EMM was usually not longer than 3 years. Standard treatment for patients...

Full description

Bibliographic Details
Main Authors: Ying Qian, Zijun Qian, Xiujie Zhao, Wenjue Pan, Xinzheng Wei, Huimin Meng, Lin Yang, Haowen Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Medicine
Subjects:
extramedullary multiple myeloma
chimeric antigen receptor T-cell
refractory
haploidentical allogeneic hematopoietic stem cell transplantation
multiple myeloma
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.649824/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.649824/full

Similar Items